FSD Pharma Inc.
FSD Pharma Inc. (HUGE) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001771885 · HUGE · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001771885 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
FSD Pharma Inc. (NASDAQ: HUGE) has submitted 340 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001771885, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is FSD Pharma Inc.'s most comprehensive regulatory disclosure. The most recent FSD Pharma Inc. 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical HUGE 10-K annual reports are available from 2019 through 2026.
Investors researching FSD Pharma Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
HUGE SEC Filings · 8 questionsFSD Pharma Inc. (HUGE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 340 filings and access original documents at no cost. FSD Pharma Inc.'s CIK is 0001771885.